SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Neonatal Group B Streptococcal Infection in Australia: A Case-control Study.

Yanni, M; Stark, M; Francis, L; Francis, JR; McMillan, M; Baird, R; Heath, PT; Gordon, A; Riccardione, J; Wilson, A; et al. Yanni, M; Stark, M; Francis, L; Francis, JR; McMillan, M; Baird, R; Heath, PT; Gordon, A; Riccardione, J; Wilson, A; Lee, R; Chooi, K; Quinn, O-P; Marshall, HS (2023) Neonatal Group B Streptococcal Infection in Australia: A Case-control Study. Pediatr Infect Dis J, 42 (5). pp. 429-435. ISSN 1532-0987 https://doi.org/10.1097/INF.0000000000003881
SGUL Authors: Heath, Paul Trafford

[img]
Preview
PDF Accepted Version
Available under License ["licenses_description_publisher" not defined].

Download (1MB) | Preview

Abstract

BACKGROUND: To determine maternal and neonatal risk factors for, and incidence of, neonatal early-onset group B streptococcus (EOGBS) and late-onset (LOGBS) infection in South Australia (SA) and the Northern Territory (NT). METHODS: A case-control study with 2:1 matched controls to cases. The study included tertiary hospitals in South Australia and the Northern Territory, Australia. Retrospective data were collected from a 16-year epoch (2000-2015). RESULTS: Of a total of 188 clinically suspected or confirmed cases, 139 were confirmed, of which 56.1% (n = 78) were EOGBS and 43.9% (n = 61) were LOGBS. The incidence of clinically suspected and confirmed cases of EOGBS was 0.26/1000 live births in SA and 0.73/1000 live births in the NT, and the incidence of confirmed cases was 0.19/1000 for SA and 0.36/1000 for the NT. The incidence of clinically suspected or confirmed LOGBS was 0.18/1000 live births in SA and 0.16/1000 for the NT. The majority of infants with GBS presented with sepsis, pneumonia, or meningitis. Developmental delay was the most commonly recorded long-term complication at 1 year old. Risk factors for EOGBS included maternal GBS carriage, previous fetal death, identifying as Aboriginal and/or Torres Strait Islander, and maternal fever in labor/chorioamnionitis. CONCLUSIONS: GBS remains a leading cause of neonatal morbidity and mortality. Adding previous fetal death to GBS screening guidelines would improve GBS prevention. The introduction of maternal GBS vaccination programs should be guided by country-specific disease epidemiology.

Item Type: Article
Additional Information: This is a non-final version of an article published in final form in Yanni, M; Stark, M; Francis, L; Francis, JR; McMillan, M; Baird, R; Heath, PT; Gordon, A; Riccardione, J; Wilson, A; et al. (2023) Neonatal Group B Streptococcal Infection in Australia: A Case-control Study. Pediatr Infect Dis J, 42 (5). pp. 429-435.
Keywords: Pregnancy, Infant, Newborn, Infant, Female, Humans, Pregnancy Complications, Infectious, Antibiotic Prophylaxis, Case-Control Studies, Retrospective Studies, Infectious Disease Transmission, Vertical, Streptococcal Infections, Streptococcus agalactiae, Northern Territory, Incidence, Fetal Death, Humans, Streptococcus agalactiae, Streptococcal Infections, Pregnancy Complications, Infectious, Fetal Death, Antibiotic Prophylaxis, Incidence, Case-Control Studies, Retrospective Studies, Pregnancy, Infant, Infant, Newborn, Northern Territory, Female, Infectious Disease Transmission, Vertical, group B streptococcal infection, group B streptococcus, fetal death, intrapartum antibiotic prophylaxis, Antibiotic Prophylaxis, Case-Control Studies, Female, Fetal Death, Humans, Incidence, Infant, Infant, Newborn, Infectious Disease Transmission, Vertical, Northern Territory, Pregnancy, Pregnancy Complications, Infectious, Retrospective Studies, Streptococcal Infections, Streptococcus agalactiae, 1114 Paediatrics and Reproductive Medicine, 1117 Public Health and Health Services, Pediatrics
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: Pediatr Infect Dis J
ISSN: 1532-0987
Language: eng
Dates:
DateEvent
1 May 2023Published
16 March 2023Published Online
10 January 2023Accepted
Publisher License: Publisher's own licence
Projects:
Project IDFunderFunder ID
PF APP1155066National Health and Medical Research Councilhttp://dx.doi.org/10.13039/501100000925
PubMed ID: 36929884
Web of Science ID: WOS:000970325200031
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/115668
Publisher's version: https://doi.org/10.1097/INF.0000000000003881

Actions (login required)

Edit Item Edit Item